Caraco Pharmaceutical Laboratories, Ltd.

Form 483 issued May 30, 2020 · Detroit, Michigan

Inspection
May 21, 2013 – May 30, 2020
Observations
1
Pages
1
FEI number
1833173

In short: On May 30, 2020, FDA issued a Form 483 with 1 observation to Caraco Pharmaceutical Laboratories, Ltd. in Detroit, Michigan (FEI 1833173) after an inspection that ran May 21, 2013 – May 30, 2020. The investigators were Aurora-Miha Trifanov and Emily J. Orban. Most observations concern materials; the most-cited regulation is 21 CFR 211.94 (drug product containers and closures).

At a glance

1 of 1 observations on this 483 concern materials.

Materials1

Most cited: 21 CFR 211.94 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Container closure systems do not provide adequate protection against foreseeable external factors in storage and use…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Caraco Pharmaceutical Laboratories, Ltd.?

FDA listed 1 observation on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.94 (drug product containers and closures). The opening words of each observation are shown on this page.

Who inspected Caraco Pharmaceutical Laboratories, Ltd.?

Aurora-Miha Trifanov and Emily J. Orban are named on this Form 483, for the inspection of May 21, 2013 – May 30, 2020. Each investigator has a profile showing what they cite most.

When was Caraco Pharmaceutical Laboratories, Ltd. inspected by FDA?

The inspection ran May 21, 2013 – May 30, 2020, and the Form 483 is dated May 30, 2020.

How do I get the full Form 483 for Caraco Pharmaceutical Laboratories, Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free